Whitepaper - Pharmaceutical Executive



Top 30 Accountable Care Organizations in the U.S.

April 29, 2014

Under Accountable Care Organizations (ACOs), decision making is highly coordinated and centralized to maximize efficiency and reduce costs. ACOs have significant control over decisions related to prescriptions, treatment, sales-rep access, and more. Download this OneKey report to identify the top 30 ACOs in the U.S. ranked by the total number of facilities and participating physicians.

Enabling Holistic, Strategic Risk-Based Monitoring

April 11, 2014

This white paper examines the current state of risk-based monitoring. It reviews the limitations of current eClinical technology to support monitoring best practices, and why sponsors and CROs are shifting to comprehensive, real-time analytics to conduct a strategic risk-based monitoring program.

Best Practices in Digital Journal App Advertising

April 1, 2014

Tablets are revolutionizing the way healthcare professionals access clinical content. Learn how digital journals are leveraging interactive learning to enhance reader experience and usage. Discover the unique advantages of journal in-app advertising. Explore practical tips and case examples that maximize the impact of multimedia content and create meaningful brand experiences.

When Marketing for Adherence, Don’t Ignore the Silent Majority

April 1, 2014

The importance of adherence is well recognized by industry, government, and a variety of healthcare experts. But motivating adherence is not always well understood. In this paper, inVentiv Health’s PMG shows how behavioral science, combined with online data and scientific evidence, can facilitate the behavior changes that can make a real difference to individual and public health.

Finding Feasibility: A Digital Discussion on Identifying Viable Products

March 25, 2014

Ken Phelps, Camargo Pharmaceutical Services president and CEO, sat down withPharmaceutical Executive to discuss identifying and pursuing the most viable products for development. In this Q&A session, Phelps shares his insight on how generics companies are overcoming the patent cliff and how Camargo goes about assessing the feasibility of drug candidates. He explains the success factors in identifying viable products that the Camargo team evaluates and how that evaluation can set the cornerstone of a time- and cost-effective development plan via the 505(b)(2) pathway. This interview will give you an inside look at how pharmaceutical companies and product developers are best preparing for the future and how you can too.

Market Profile of U.S. Oncologists

March 7, 2014

This OneKey report provides actionable insights on oncologists, an important group of specialists treating America's second deadliest disease category. Use it to formulate better marketing and engagement strategies with oncologists.

Global Digital Security: The Human Element

February 28, 2014

The health care industry will be among the most susceptible industries to publicly disclosed and widely scrutinized data breaches. Learn how to protect private data by developing a comprehensive strategy for preventing, preparing and responding to attacks.

Connected Healthcare

March 31, 2014

Connected Healthcare: Adding new pharma brand value by unlocking outcomes measurement with mobile technology, behavior-change programs, compliance programs, and facilitated data exchange.

Reprints at the Dawn of the 'Sunshine Act'

January 28, 2014

Medical journal article reprints provide health care professionals credible clinical evidence that a product works. Read about the new reprint regulations emerging from the Sunshine Act. Learn about newer ePrint formats and discover new distribution channels to get the right article to the right prescriber at the right time.


Click here